Actively Recruiting

Age: 18Years +
All Genders
NCT04979728

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

Led by University of Colorado, Denver · Updated on 2026-03-03

150

Participants Needed

1

Research Sites

317 weeks

Total Duration

On this page

Sponsors

U

University of Colorado, Denver

Lead Sponsor

N

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to establish an operational framework for home self-collections of blood samples to be used for antiviral drug concentration measurements. Participants will continue on their prescribed antiviral(s) for HIV treatment or prevention and followed for up to approximately 1 year. The investigators will compare drug concentrations of antivirals and relevant metabolites/anabolites in clinic-collected and self-collected blood samples.

CONDITIONS

Official Title

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years old or older
  • Receiving one or more antivirals for HIV treatment or prevention, including oral or long-acting injectable options
  • Current patient at the UCH-IDGP clinic
  • Able to comply with study procedures including observed self-collection of dried blood spots and completion of surveys
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Unable or unwilling to comply with observed self-collection of blood samples including video monitoring
  • Any uncontrolled medical, social, or mental health issues that could interfere with participation or outcomes (e.g., incarceration)
  • Any medical condition affecting drug pharmacokinetics such as acute kidney injury, liver problems, significant drug interactions, active hemolysis, or symptomatic hemoglobinopathies
  • Women who become pregnant while on long-acting injectable antivirals may participate only if their provider continues the regimen

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Colorado Hospital (UCHealth)

Aurora, Colorado, United States, 80045

Actively Recruiting

Loading map...

Research Team

R

Ryan Coyle, MPH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here